Linyong Xu
- Molecular Biology
- Oncology
- Pediatrics, Perinatology and Child Health top 10%
- Epidemiology
- Pharmacology top 5%
- Co-authors
- Mingyi ZhaoQuan ZhuangXinyu LiQingnan HeYijing HeZeyu WangWei ZhangGan Zhou
- Topics
- Drug Transport and Resistance Mechanisms (5 papers)Pharmacological Effects and Toxicity Studies (4 papers)SARS-CoV-2 and COVID-19 Research (2 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Linyong Xu
34 papers receiving 735 citations
Peers
Comparison fields: 5 of 117
- Molecular Biology 187
- Oncology 177
- Pediatrics, Perinatology and Child Health 121
- Epidemiology 113
- Pharmacology 93
Countries citing papers authored by Linyong Xu
This map shows the geographic impact of Linyong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linyong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linyong Xu more than expected).
Fields of papers citing papers by Linyong Xu
This network shows the impact of papers produced by Linyong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linyong Xu. The network helps show where Linyong Xu may publish in the future.
Co-authorship network of co-authors of Linyong Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Linyong Xu. A scholar is included among the top collaborators of Linyong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linyong Xu. Linyong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 42 | |
| 6 | 34 | |
| 7 | 7 | |
| 8 | 1 | |
| 9 | 23 | |
| 10 | 8 | |
| 11 | 6 | |
| 12 | 1 | |
| 13 | 9 | |
| 14 | 12 | |
| 15 | 5 | |
| 16 | 8 | |
| 17 | 70 | |
| 18 | 58 | |
| 19 | 64 | |
| 20 | 37 |
About Linyong Xu
Linyong Xu is a scholar working on Transplantation, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 35 papers that have together received 740 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Pharmacological Effects and Toxicity Studies (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Pharmacology (93 citations), Oncology (177 citations) and Pediatrics, Perinatology and Child Health (121 citations). Linyong Xu has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Mingyi Zhao, Quan Zhuang, Xinyu Li, Qingnan He, Yijing He, Zeyu Wang, Wei Zhang, Gan Zhou, Wei Zhang and Sheng Deng. Their work appears in journals such as PLoS ONE, Information & Management and World Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.